Pharmaceutical group ยท Slovenia
Krka
A group of 21 companies with 1,845 medicines in 8 countries.
Group structure
21 companies in 8 countries
Loadingโฆ
Pharmaceutical group ยท Slovenia
A group of 21 companies with 1,845 medicines in 8 countries.
21 companies in 8 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 1,845
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abidalo 2,5 mg filmom obloลพene tableteFilmom obloลพena tableta | Apixaban | Croatia | Not marketed | 2026 |
| Abidalo 5 mg filmom obloลพene tableteFilmom obloลพena tableta | Apixaban | Croatia | Not marketed | 2026 |
| Abirateron Krka500mg ยท film tableta | Abiraterone | Serbia | Authorised | 2022 |
| Abirateron Krka500mg ยท film tableta | Abiraterone | Serbia | Authorised | 2022 |
| Abirateron Krka500mg ยท film tableta | Abiraterone | Serbia | Authorised | 2022 |
| Abirateron Krka500mg ยท film tableta | Abiraterone | Serbia | Authorised | 2022 |
| ABIRATERONA KRKA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg ยท Comprimido recubierto con pelรญcula | Abiraterone | Spain | Marketed | 2021 |
| Abiraterone Krka | Abiraterone | EU (EMA) | Authorised | 2021 |
| Abiraterone Krka 500 mg, filmomhulde tablettenFilmomhulde tablet | Abiraterone | Netherlands | Authorised | 2021 |
| Aboxoma5mg ยท film tableta | Apixaban | Serbia | Authorised | 2022 |
| Aboxoma2.5mg ยท film tableta | Apixaban | Serbia | Authorised | 2022 |
| Aboxoma2.5mg ยท film tableta | Apixaban | Serbia | Authorised | 2022 |
| Aboxoma 2,5 mg filmom obloลพene tableteFilmom obloลพena tableta | Apixaban | Croatia | Not marketed | 2026 |
| Aboxoma 5 mg filmom obloลพene tableteFilmom obloลพena tableta | Apixaban | Croatia | Not marketed | 2026 |
| ACIDO ACETILSALICILICO KRKA 100 MG COMPRIMIDOS GASTRORRESISTENTES100 mg ยท Comprimido gastrorresistente | Acetylsalicylic acid | Spain | Marketed | 2017 |
| Aclexa 100 mg tvrde kapsulekapsula, tvrda | Celecoxib | Croatia | Marketed | 2019 |
| Aclexa 200 mg tvrde kapsulekapsula, tvrda | Celecoxib | Croatia | Marketed | 2019 |
| Adolax 10 mg/5 mg tablete s produljenim oslobaฤanjemtableta s produljenim oslobaฤanjem | Oxycodone, Naloxone | Croatia | Marketed | 2021 |
| Adolax 20 mg/10 mg tablete s produljenim oslobaฤanjemtableta s produljenim oslobaฤanjem | Oxycodone, Naloxone | Croatia | Marketed | 2021 |
| Adolax 40 mg/20 mg tablete s produljenim oslobaฤanjemtableta s produljenim oslobaฤanjem | Oxycodone, Naloxone | Croatia | Marketed | 2021 |
| Agomaval 25 mg, filmomhulde tablettenFilmomhulde tablet | Agomelatine | Netherlands | Authorised | 2018 |
| ALPRAZOLAM KRKA 0.25 MG COMPRIMIDOS EFG0.250 mg ยท Comprimido | Alprazolam | Spain | Marketed | 2018 |
| Alprazolam Krka 0,25 mg tabletetableta | Alprazolam | Croatia | Not marketed | 2022 |
| ALPRAZOLAM KRKA 0.5 MG COMPRIMIDOS EFG0.500 mg ยท Comprimido | Alprazolam | Spain | Marketed | 2018 |
| Alprazolam Krka 0,5 mg tabletetableta | Alprazolam | Croatia | Not marketed | 2022 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Croatia | 493 | 493 | 0 | CompaniesAll medicines |
| Spain | 460 | 400 | 60 | CompaniesAll medicines |
| Serbia | 434 | 424 | 10 | CompaniesAll medicines |
| Netherlands | 231 | 231 | 0 | CompaniesAll medicines |
| Romania | 187 | 0 | 187 | CompaniesAll medicines |
| European Union (EMA) | 31 | 24 | 7 | CompaniesAll medicines |
| Saudi Arabia | 8 | 8 | 0 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of France, Malaysia, Singapore, Sweden, United Kingdom, United States
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods JanuaryโSeptember 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Keep Krkaโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.